SCHEMBL16619099

SCHEMBL16619099

CCC(c1cc(C)[nH]n1)c1ccccc1C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 4/20 0.39
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCNA1 P78396 1/20 0.37
CD38 P28907 1/20 0.36
DAO P14920 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
CTSA P10619 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
FGFR1 P11362 1/20 0.35
FGFR2 P21802 1/20 0.35
FGFR3 P22607 1/20 0.35
RPS6KB1 P23443 1/20 0.34
PLA2G10 O15496 1/20 0.33
PLA2G2A P14555 1/20 0.33
AURKA O14965 1/20 0.33
AURKB Q96GD4 1/20 0.33
PARP1 P09874 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4976973 0.76 RPS6KB1 (0.44) RPS6KB1PARP1
SCHEMBL474162 0.69 KDM4E (0.45) FGFR1FGFR2FGFR3RPS6KB1PARP1
SCHEMBL8720079 0.68 HCAR2 (0.46) CCNA2CDK2CCNA1DAOHCAR2
SCHEMBL1380696 0.68 TSHR (0.55) PARP1
SCHEMBL11503111 0.68 KDM4E (0.44) FGFR1FGFR2FGFR3PARP1
SCHEMBL3262898 0.68 KDM4E (0.44) FGFR1FGFR2FGFR3PARP1
SCHEMBL8526511 0.68 TSHR (0.55) PARP1
SCHEMBL16619753 0.68 GPR84 (0.42) BRD4CCNA2CDK2CCNA1CD38
SCHEMBL6277238 0.66 NNMT (0.47) RPS6KB1AURKA
SCHEMBL3381004 0.65 BCAT2 (0.42) FGFR1FGFR2FGFR3RPS6KB1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052099-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2016-08-10 EP claimed
WO-2015050798-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2015-04-09 WO claimed
EP-3052099-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2016-08-10 EP disclosed
WO-2015050798-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2015-04-09 WO disclosed